MetLife, Inc. (MET) Valuation
Historical valuation analysis based on 1279 data points (2021-09-14 to 2026-10-16)
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: group benefits, retirement and inco...
MetLife, Inc. (MET) currently trades at a P/E ratio of 17.66 (historical range: 7.04–27.92, median: 16.46), placing it at the 61th percentile — above its historical average, P/S ratio of 0.81 (range: 0.55–1.01, 53th percentile — near its historical average), EV/EBITDA of 7.35 (range: 1.92–16.56, 60th percentile).
Over the historical period (2021-09-14 to 2026-10-16), MetLife, Inc.'s P/E ratio has contracted by 14% over the observed period (from an average of 19.0 to 16.4).
MetLife, Inc. trades above its historical valuation range, with most metrics above their median levels.
Historical Valuation Metrics
| Metric | Current | Median | %ile | Assessment |
|---|---|---|---|---|
| P/E Ratio | 17.66 | 16.46 | 61th | above its historical average |
| P/S Ratio | 0.81 | 0.80 | 53th | near its historical average |
| EV/EBITDA | 7.35 | 6.72 | 60th | above its historical average |
MetLife, Inc. (MET) Valuation & P/E History
MetLife, Inc. (MET) is a US-listed stock operating in the Financial Services sector, specifically the Life Insurance industry currently trading at $101.00 with a market capitalization of $64.2 billion. This page provides historical valuation analysis for MET based on 1279 data points covering 2021-09-14 to 2026-10-16. The P/E ratio of 17.66 is above the historical median of 16.46, placing MET at the 61th percentile of its valuation range. The P/S ratio of 0.81 compares to a median of 0.80.
MET Valuation Metrics & Historical Range
The valuation table above shows MetLife, Inc.'s current and historical valuation multiples, including P/E ratio, P/S ratio, EV/EBITDA, FCF yield, and dividend yield. Each metric is compared to its own historical range to determine whether MET is currently trading above or below its typical valuation levels.
- P/E ratio: Price-to-earnings measures how much investors pay per dollar of earnings. A P/E above the historical median suggests MET is expensively valued; below the median suggests it is cheap.
- P/S ratio: Price-to-sales is useful for companies with volatile or negative earnings. Lower P/S relative to history may indicate value.
- EV/EBITDA: Enterprise value to EBITDA adjusts for debt and cash, providing a capital-structure-neutral valuation measure for MetLife, Inc..
- FCF yield: Free cash flow yield shows the cash return relative to market price. Higher yields may indicate undervaluation.
Is MET Overvalued or Undervalued?
MetLife, Inc. trades above its historical valuation range, with most metrics above their median levels. The overall valuation percentile of 58 combines P/E, P/S, and EV/EBITDA percentiles into a single measure of how expensive MET is relative to its own history. A percentile below 25 suggests the stock may be undervalued, while a percentile above 75 suggests it may be overvalued.
However, valuation is only one factor in investment decisions. A stock can remain "overvalued" for years if growth accelerates, or "undervalued" if the business deteriorates. Always combine valuation analysis with financial statement analysis and the full MET analysis page for a complete picture.
Valuation data is computed from historical price and fundamental data via Polygon.io and Finnhub.MET trades on NYSE. This page is for informational purposes only and is not financial advice.